Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Leukin is used as maintenance therapy for acute lymphatic (lymphocytic, lymphoblastic) leukemia, given as part of a combination regimen. How well a patient responds to this medicine depends on the particular subtype of acute lymphatic leukemia and on the patient's age (child or adult).

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Mercaptopurine belongs to a class of medicines called purine antagonists. Once inside the body's cells, it is converted into active compounds, including thioinosinic acid. These compounds block several steps that cells need to build nucleic acids, stopping the formation of RNA and DNA.

Pregnancy & Breastfeeding

Mercaptopurine belongs to pregnancy category D. This means there is positive evidence of risk to the human foetus. Even so, the benefits of using it in pregnant women may outweigh that risk in some cases, for example when the medicine is needed in a life-threatening situation, or for a serious disease where safer medicines cannot be used or do not work.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Crohn's disease Adults: Start with 1 to 1.5 mg/kg daily. The dose may be increased to 125 mg daily. Children: Start with 1 to 1.5 mg/kg daily. The dose may be increased to a maximum of 75 mg daily. Acute lymphocytic leukaemia Adults: The usual maintenance dose starts at 1.5 to 2.5 mg/kg daily, taken as a single dose, and is usually given in combination with methotrexate. The dose may vary from person to person depending on response and tolerance. Blood counts should be checked at least once a week. Treatment must be stopped immediately if there is a sharp drop in the white cell count or severe bone marrow depression. Treatment may be restarted slowly and carefully once the white cell count has stayed steady for 2 to 3 days or has begun to rise. The dose should be reduced when used together with allopurinol. Children: The usual maintenance dose starts at 1.5 to 2.5 mg/kg daily, taken as a single dose, and is usually given in combination with methotrexate. The dose may vary from child to child depending on response and tolerance. Blood counts should be checked at least once a week. Treatment must be stopped immediately if there is a sharp drop in the white cell count or severe bone marrow depression. Treatment may be restarted slowly and carefully once the white cell count has stayed steady for 2 to 3 days or has begun to rise. The dose should be reduced when used together with allopurinol.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.